AngioDynamic’s NanoKnife device uses electrodes to kill cancer cells. The surgery for prostate cancer takes about an hour. COLONIE — Latham-based medical technology company AngioDynamics is ramping up ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Palmetto GBA Medicare Coverage Effective July 5, 2026 Advances NanoKnife IRE Reimbursement Access in Prostate and Liver Cancer, Building on Category I CPT Codes Toward Broader National Payer Coverage ...
The FDA’s 510(k) clearance was based in part on the company’s pivotal PRESERVE study, which reported 84% of men with no clinically significant disease after 12 months. (Photo by Sarah Silbiger/Getty ...
TIME names NanoKnife one of 2025’s Best Inventions — already treating prostate cancer in Toronto with precise, function-preserving results. TIME's recognition of NanoKnife (IRE) reinforces what we’ve ...
UnityPoint Health – St. Luke's Hospital has become the first hospital in the Cedar Rapids metro area to offer NanoKnife ...
AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment ...
PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results